If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

BPH Surgery Complication Rates Underestimated

April 30, 2012

PARIS—Complication rates after surgery for benign prostatic hyperplasia (BPH) are higher in real clinical practice than in clinical trials.
 

Novel Drug for Overactive Bladder Works Even If Antimuscarinics Do Not

February 29, 2012

PARIS—Mirabegron, an experimental drug for overactive bladder (OAB), can effectively treat the condition in patients whether or not they failed previous antimuscarinic therapy, according to findings presented at the 27th Annual Congress of the European Association of Urology.
 

Bladder Cancer Death Risk May No Longer Be Higher in Women

February 27, 2012

PARIS—Previous research has shown that cancer-specific survival (CSS) after radical cystectomy for bladder cancer is significantly worse for women than men, but new data presented at the 27th Annual Congress of the European Association of Urology suggest that this may no longer be the case.
 

Hemodialysis Patients Not More Likely to Die from Renal Cell Carcinoma

February 27, 2012

PARIS—Hemodialysis (HD) patients are no more likely to die from renal cell carcinoma (RCC) than patients with normal renal function, but they have decreased overall survival, Japanese investigators reported at the 27th Annual Congress of the European Association of Urology.
 

Immediate Salvage Radiotherapy Urged for Recurrent PCa

February 27, 2012

PARIS—Salvage radiotherapy (SRT) for recurrent prostate cancer (PCa) should be given at the earliest sign of biochemical failure, researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Data Support Cystoscopy Prior to Brachytherapy

February 27, 2012

PARIS—Cystoscopy prior to low dose rate (LDR) brachytherapy for prostate cancer is feasible and useful in identifying patients who require further investigation or intervention before seed implantation, researchers reported at the 27th Annual Congress of the European Association of Urology.
 

High-Grade Prostate Cancer Linked to Metabolic Syndrome

February 27, 2012

PARIS—Metabolic syndrome does not increase men's risk of prostate cancer (PCa) overall, but it does increase their risk of aggressive PCa, researchers reported at the 27th Annual Congress of the European Association of Urology.
 

PDE-5 Inhibitors Improve LUTS in Men

February 26, 2012

PARIS—Phosphodiesterase-5 (PDE-5) inhibitors significantly improve lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and can be considered as an alternative treatment for BPH-related LUTS in men with or without erectile dysfunction, researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Shockwave Therapy Found to Improve Erectile Dysfunction

February 26, 2012

PARIS—Low-intensity extracorporeal shockwave therapy (LI-ESWT) is an effective treatment option for men with vasculogenic erectile dysfunction (ED), according to findings presented at the 27th Annual Congress of the European Association of Urology.
 

Study: Partial Nephrectomy Complications Mostly Minor

February 26, 2012

PARIS—Nearly one quarter of patients undergoing partial nephrectomy (PN) experience complications, but most are minor, a researcher reported at the 27th Annual Congress of the European Association of Urology.
 

Partial Nephrectomy Rates Rise, but Disparities Exist

February 26, 2012

PARIS—Partial nephrectomy (PN) rates have increased dramatically, but this surgical approach is underused in certain patient populations, according to data presented at the 27th Annual Congress of the European Association of Urology.
 

NSAID Use May Increase Prostate Cancer Risk

February 25, 2012

PARIS—Contrary to the findings of previous epidemiologic studies, a new study found that use of nonsteroidal anti-inflammatory agents (NSAIDs) is associated with an increased risk of prostate cancer (PCa) overall and aggressive PCa, Finnish researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Metabolic Syndrome Raises BPH Risk

February 25, 2012

PARIS—Metabolic syndrome increases a man's risk of developing benign prostatic hyperplasia (BPH) and the risk of prostatic inflammation in men who have BPH, according to reports at the 27th Annual Congress of the European Association of Urology.
 

Prophylactic Antibiotics Unnecessary for Outpatient Cystoscopy

February 25, 2012

PARIS—Antibiotic prophylaxis and risk-based stratification are unnecessary for most patients undergoing outpatient flexible cystoscopy, researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Renal Dysfunction After Radical Nephrectomy Raises Cardiovascular Risks

February 25, 2012

PARIS—Renal dysfunction following radical nephrectomy (RN) for renal cancer is associated with an increased risk of cardiovascular (CV) events and non-cancer-related mortality, Japanese researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Post-Prostate Biopsy Infections a Significant Global Problem

February 25, 2012

PARIS—Infectious complications following a transrectal prostate biopsy have become a significant health problem globally, data presented at the 27th Annual Congress of the European Association of Urology suggest.
 

Flexible Ureteroscopy Suitable for Obese Stone Patients

February 25, 2012

PARIS—Flexible ureteroscopy can be an effective treatment for kidney stones in obese and overweight patients, according to data presented at the 27th Annual Congress of the European Association of Urology. The procedure is associated with a low complication rate in these patients, according to researchers.
 

Botulinum Toxin Eases LUTS in Men

March 22, 2011

VIENNA—Botulinum toxin type A (BTA) injected into the prostate may be a safe and effective treatment for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), according to preliminary study results presented here at the 26th Annual Congress of the European Association of Urology.
 

Novel Cause of BPH, PCa Proposed

March 22, 2011

VIENNA—Benign prostatic hyperplasia (BPH) and prostate cancer could be the result a previously unrecognized route of free testosterone flow from the testes to the prostate, according to investigators.
 

Real-Time Elastography Superior for Identifying Prostate Cancer

March 22, 2011

VIENNA—Real-time elastography has significantly better predictive accuracy for identifying prostate cancer (PCa) lesions compared with contrast-enhanced magnetic resonance imaging (MRI), researchers reported here at the 26th Annual Congress of the European Association of Urology. Biopsy studies need to confirm these results, however.
 

BoNT-A Efficacy for Idiopathic Detrusor Overactivity Confirmed

March 21, 2011

VIENNA—Findings from a large randomized trial confirm the effectiveness of botulinum toxin type A (BoNT-A) for refractory idiopathic detrusor overactivity (IDO) in women.
 

Five-Year RARP Outcomes 'Highly Satisfactory'

March 21, 2011

VIENNA—Robot-assisted radical prostatectomy (RARP) for localized prostate cancer (PCa) offers "highly satisfactory" five-year oncologic outcomes, according to investigators.
 

Drug May Be an Alternative to Cystectomy for BCG Failures

March 21, 2011

VIENNA—Mycobacterial cell wall DNA complex (MCC) may provide an alternative to cystectomy for patients with non-muscle invasive bladder cancer refractory to bacillus Calmette-Guérin (BCG) treatment, according to preliminary study findings.
 

Testosterone Safe for Prostates

March 20, 2011

VIENNA—Testosterone replacement therapy benefits hypogonadal men without adversely affecting prostate safety, according to the largest international trial of hypogonadal men receiving the treatment.
 

Tadalafil Helps Men with Both ED and BPH-LUTS

March 20, 2011

VIENNA—Tadalafil can improve erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) in men who suffer from both problems, data suggest.
 

High-Grade PCa Linked to Metabolic Syndrome

March 20, 2011

VIENNA—Metabolic syndrome is associated with an increased risk of high-grade prostate cancer (PCa) among men with a positive prostate biopsy, a study found.
 

CKD Develops in Many Living Kidney Donors

March 19, 2011

VIENNA—One year after undergoing living donor nephrectomy (LDN), more than half of donors will have chronic kidney disease (CKD), according to a British study. Their decline in renal function, however, appears to remain stable for at least five years and patients rarely suffer adverse cardiovascular events and cardiac mortality.
 

PSA Screening Lowers Metastasis Risk

March 19, 2011

VIENNA—PSA screening for prostate cancer (PCa) decreases the risk of PCa-related metastatic disease, according to study findings presented at the European Association of Urology 26th annual congress.
 

LUTS May Indicate Lower PCa Risk

March 19, 2011

VIENNA—Lower urinary tract symptoms (LUTS) in men may provide useful information about the risk of having prostate cancer (PCa) diagnosed, data from two studies presented at the 26th Annual Congress of the European Association of Urology.
 

Metallic Ureteral Stents Found Superior

July 28, 2010

These devices improved patient quality of life significantly better than conventional plastic stents.
 

More Bladder Cancer Is Metastatic at Diagnosis

July 28, 2010

BARCELONA—Researchers have documented a small but significant stage migration in metastatic bladder cancer between 1988 and 2006.
 

Obesity Does Not Alter RALP Outcomes

June 18, 2010

Obese and non-obese patients had comparable continence and potency rates one year after surgery.
 

RALP May Be Better than Active Surveillance

May 04, 2010

BARCELONA—Prostate cancer patients who are eligible for active surveillance may actually benefit from robotic-assisted laparoscopic prostatectomy (RALP), according to data announced at the 25th Anniversary European Association of Urology Congress.
 

Stick with Quinolones for Prostate Biopsies

May 03, 2010

Using penicillin instead may result in a higher risk of sepsis, according to British researchers.
 

PSA Screening Cuts Prostate Cancer Death Risk

May 01, 2009

PSA screening for prostate cancer is associated with a 20% reduction in mortality from the disease, according to findings from the largest prostate cancer study ever conducted.
 

Finasteride's PCa Benefits Confirmed

April 07, 2009

New findings from a Finnish study confirm previous research that finasteride use is associated with a decreased risk of prostate cancer.
 

Intermittent Therapy May Be an Option for LUTS

March 20, 2009

Intermittent alpha blocker therapy is a feasible strategy for men suffering from lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO), a researcher has concluded.
 

Flexible Ureteroscopy At Least As Effective as ESWL for Large Stones

March 20, 2009

Flexible ureteroscopy and lasertripsy (FURSL) for treating renal stones larger than 1 cm in diameter is associated with high success rates, data show.
 

PNL Superior for Lower Pole Calyceal Stones

March 20, 2009

Percutaneous nephrolithotomy (PNL) is superior to shock wave lithotripsy (SWL) and observation for treating asymptomatic lower pole calyceal stones, according to Turkish researchers.
 

Prostate Cancer Found in 10% of Men Having BPH Surgery

March 20, 2009

German researchers found that one in 10 men undergoing laser surgery for benign prostatic hyperplasia (BPH) also had prostate cancer (PCa).
 

Risk Factors for Post-TURP Urinary Tract Infections Identified

March 20, 2009

Patients who have urinary catheters in place upon hospital admission for transurethral resection of the prostate (TURP) are at increased risk of post-operative urinary tract infections (UTIs), investigators reported at the 24th Annual European Association of Urology Congress in Stockholm.
 
Popular Topics
Acute Kidney Injury AKI Androgen Deprivation Anemia Benign Prostatic Hyperplasia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease Circumcision CKD CVD Diabetes Dialysis End-stage Renal Disease Hemodialysis Kidney Cancer Overactive Bladder Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Secondary Hyperparathyroidism Transplantation Urinary Incontinence Urology

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions